Investment
Features
FeesSafety
Academy
More
Pluang+

TuHURA Biosciences secures patent for Delta Opioid Receptor antagonists boosting cancer immunotherapy.

Company Fundamentals
05 Oct 2026
PRNewsWire
View Source
Bullish
TuHURA Biosciences secures patent for Delta Opioid Receptor antagonists boosting cancer immunotherapy.

TuHURA Biosciences announced the issuance of a U.S. patent for their Delta Opioid Receptor (DOR) antagonist technology, which reprograms immunosuppressive cells to enhance cancer immunotherapy. This patent covers the use of DOR antagonists in combination therapies, including adoptive cellular immunotherapies like CAR-T, Tregs, and TIL therapies, aiming to overcome resistance in cancer treatments. The technology targets Myeloid Derived Suppressor Cells to prevent T cell exhaustion, a major barrier in effective immunotherapy. The patent extends through 2043, supporting TuHURA's ongoing development of novel cancer therapies in clinical trials.

TuHURA Biosciences' recent U.S. patent extends through 2043, supporting its innovative cancer immunotherapy development. For readers following the health sector, here is Pluang's market snapshot as of Oct 05, 2026 18:12 WIB: out of 100 priced health-sector US stocks, 41 rose and 41 fell. Notable movers include BioNano Genomics Inc (BNGO) at USD 1.48 with a -1.33% change, 10X Genomics Inc (TXG) at USD 94.72 with a +1.30% change, and Zimmer Biomet Holdings Inc (ZBH) at USD 89.44 with a +1.30% change. Typical hold times on Pluang range from 49 to 93 days for these stocks.

More News

New data show EBGLYSS and combo Taltz-Zepbound improve treatment for atopic dermatitis, psoriasis, and obesity.

New data show EBGLYSS and combo Taltz-Zepbound improve treatment for atopic dermatitis, psoriasis, and obesity.

Eli Lilly presented new data at the 2026 Fall Clinical Dermatology Conference highlighting EBGLYSS (lebrikizumab-lbkz) for moderate-to-severe atopic dermatitis, showing durable disease control with less frequent dosing and reduced topical treatment. ...

Market News
Bullish
4 hours ago
Tyson Foods' dividend remains safe despite losses in its beef business due to strong chicken and prepared foods profits.

Tyson Foods' dividend remains safe despite losses in its beef business due to strong chicken and prepared foods profits.

Tyson Foods is experiencing significant losses in its beef segment, with a projected loss of $500 million to $650 million for the fiscal year, causing its stock to decline. However, the company's dividend remains secure because its chicken and prepar...

Market News
Neutral
4 hours ago
Amazon invests heavily in data centers, betting on future profits from AI and cloud growth.

Amazon invests heavily in data centers, betting on future profits from AI and cloud growth.

Amazon is investing hundreds of billions in data centers, servers, and chips, aiming for long-term returns as these assets generate revenue over decades. AWS revenue grew 37% in Q2 with a strong operating margin, and the company has a $496 billion ba...

Company Fundamentals
Bullish
4 hours ago
Northern Graphite hires DGWA to boost investor relations in Europe, focusing on German-speaking markets.

Northern Graphite hires DGWA to boost investor relations in Europe, focusing on German-speaking markets.

Northern Graphite Corporation has engaged German advisory firm DGWA to enhance its investor relations and visibility in Europe, especially in German-speaking regions. The partnership aims to attract strategic investors, institutional funds, and indus...

Market News
Bullish
4 hours ago
Bitcoin wallet activity spikes after large whale transaction alerts, especially among medium-sized wallets.

Bitcoin wallet activity spikes after large whale transaction alerts, especially among medium-sized wallets.

A Federal Reserve Bank of Philadelphia study found that Bitcoin wallet activity notably increases within 15 minutes after public alerts of large whale transactions. Medium-sized wallets showed the strongest response, with buying activity rising 23.72...

Technical Signals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App